358395-59-2

Upstream product

• 75-08-1 ethanethiol 

Downstream Products

• 552833-18-8 (5S,7R,8R)-9-(tert-butyldiphenylsilyloxy)-1,1-di(isopropyloxy)-5,7-di(triethylsilyloxy)-8-iodo-3(Z)-nonene 
• 552833-17-7 (2S,4R,5R)-6-(tert-butyldiphenylsilyloxy)-2,4-di(triethylsilyloxy)-5-iodohexanal 
• 358395-62-7 (5S,7R,8R)-9-(tert-butyldiphenylsilyloxy)-5,7-di(benzoyloxy)-1-(3,4,5,6-tetrahydro-2H-pyran-2-yloxy)-8-iodo-3(Z)-nonene 
• 358395-63-8 methyl (5S,7R,8R)-9-(tert-butyldiphenylsilyloxy)-5,7-di(benzoyloxy)-8-iodonon-3(Z)-enoate 
• 358395-57-0 (1R,2S,3S,4S)-1,4-bis-O-(benzoyl)-2-(tert-butyldiphenylsilyloxymethyl)-3-(methoxycarbonylethyl)cyclopentane-1,4-diol 
• 552833-10-0 (1R,2R,3S,4S)-1,4-di(benzoyloxy)-3-(2-methoxycarbonylethyl)-2-(7-methoxycarbonyl-3-oxoheptyl)cyclopentane 
• 358395-68-3 (1R,2R,3S,4S)-1,4-di(benzoyloxy)-3-(2-methoxycarbonylethyl)-2-(7-methoxycarbonyl-3-oxohept-1-enyl)cyclopentane 
• 358395-61-6 (2S,4R,5R)-6-(tert-butyldiphenylsilyloxy)-2,4-di(benzoyloxy)-5-iodohexanal 
• 358395-67-2 (1R,2R,3S,4S)-1,4-di(benzoyloxy)-3-(2-methoxycarbonylethyl)-2-(3-oxooctyl)cyclopentane 
• 358395-66-1 (1R,2R,3S,4S)-1,4-di(benzoyloxy)-3-(2-methoxycarbonylethyl)-2-((E)-3-oxooct-1-enyl)cyclopentane 
• 358395-64-9 (1R,2S,3S,4S)-1,4-di(benzoyloxy)-2-hydroxymethyl-3-(2-methoxycarbonylethyl)cyclopentane 
• 925433-33-6 8-[(1R,2S,3S,5R)-2-(2-Carboxy-ethyl)-3,5-dihydroxy-cyclopentyl]-6-oxo-octanoic acid 
• 358395-65-0 (1R,2R,3S,4S)-1,4-di(benzoyloxy)-2-formyl-3-(2-methoxycarbonylethyl)cyclopentane 
• 552833-16-6 (2S,4R,5R)-6-(tert-butyldiphenylsilyloxy)-2,4-di(triethylsilyloxy)-1,1-diethylthio-5-iodohexane 

Relevant academic research and scientific papers

Radical cyclization; towards the syntheses of tetranor metabolites of 15-F2t-isoprostane

Radical cyclization of acyclic 1-substituted-2,4-dihydroxylated 5-hexenyl radicals produced functionalized cyclopentane derivatives. These cyclopentanic precursors after different protection/deprotection reactions followed by Wittig and Horner-Wadsworth-E

Synthesis of the two main urinary tetranor metabolites of 15-F2t-isoprostane

The first synthesis of two main urinary tetranor metabolites of 15-F2t-isoprostane methyl ester is described using L-glucose as starting material.